Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the NHS plans to use low carbon propellants treatments for asthma and Chronic obstructive pulmonary disease patients promptly once these therapies have been approved for use by patients.

The National Health Service remains committed to reducing the carbon impact of inhalers. As part of all inhaler prescriptions, structured medication reviews and asthma reviews, consideration should be given to moving patients to lower carbon options, where it is clinically appropriate to do so.

NHS England has worked with key partners, industry representatives, patient groups, and clinicians to develop a package of guidance and resources to support improved respiratory disease management and shared decision-making on inhaler choice.